Bio-Rad Laboratories (BIO-B) Non Operating Investment Income (2018 - 2026)
Bio-Rad Laboratories (BIO-B) reported Non Operating Investment Income of -$738.2 million for Q1 2026, down 2421.38% year-over-year from $31.8 million in Q1 2025, and down 49.04% quarter-over-quarter from -$495.3 million in Q3 2025.
Bio-Rad Laboratories (BIO-B) Non Operating Investment Income (2018 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO-B) has 9 years of Non Operating Investment Income data on file, last reported at -$738.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn | -738.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -738.20 Mn |
| Mar 31, 2026 | -738.20 Mn |
| Sep 30, 2025 | -495.30 Mn |
| Sep 30, 2025 | -495.30 Mn |
| Jun 30, 2025 | 334.40 Mn |
| Jun 30, 2025 | 334.40 Mn |
| Mar 31, 2025 | 31.80 Mn |
| Mar 31, 2025 | 31.80 Mn |
| Sep 30, 2024 | 792.90 Mn |
| Sep 30, 2024 | 792.90 Mn |
| Jun 30, 2024 | -2.90 Bn |
| Jun 30, 2024 | -2.90 Bn |
| Mar 31, 2024 | 422.20 Mn |
| Mar 31, 2024 | 422.20 Mn |
| Sep 30, 2023 | 36.43 Mn |
| Sep 30, 2023 | 36.43 Mn |
| Jun 30, 2023 | -1.60 Bn |
| Jun 30, 2023 | -1.60 Bn |
| Mar 31, 2023 | -17.53 Mn |
| Mar 31, 2023 | -17.53 Mn |